$7.86
-0.16-2%
Last update: Nov 10, 4:00 PM
Maravai LifeSciences Holdings Inc
MRVINASDAQ
The average analyst price target for Maravai LifeSciences is $5.92, 24.7% below the current price. Of 9 analysts, 5 rate it Buy, 3 Hold and 1 Sell. Targets range from $2 to $10. The latest change came on Sep 9, 2026, when UBS raised its price target on Maravai LifeSciences from $2.50 to $8 and kept a Neutral rating.
Price Target Range — 11 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
